(89)Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I

RATIONALE: Epidermal growth factor receptor (EGFR) upregulation is associated with enhanced proliferation and drug resistance in a number of cancers. Nimotuzumab is a humanized monoclonal antibody with high affinity for EGFR. The objective of this study was to determine if (89)Zr-DFO-nimotuzumab cou...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Chekol, Rufael, Solomon, Viswas Raja, Alizadeh, Elahe, Bernhard, Wendy, Fisher, Darrell, Hill, Wayne, Barreto, Kris, DeCoteau, John Francis, Parada, Angel Casaco, Geyer, Clarence Ronald, Fonge, Humphrey
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908310/
https://ncbi.nlm.nih.gov/pubmed/29682209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24965
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller